197 related articles for article (PubMed ID: 24123908)
1. Vascular endothelial growth factor gene polymorphism and protein expression in the pathogenesis of pterygium.
Peng ML; Tsai YY; Tung JN; Chiang CC; Huang YC; Lee H; Cheng YW
Br J Ophthalmol; 2014 Apr; 98(4):556-61. PubMed ID: 24123908
[TBL] [Abstract][Full Text] [Related]
2. Vascular endothelial growth factor gene 460 polymorphism is associated with pterygium formation in female patients.
Tsai YY; Chiang CC; Bau DT; Cheng YW; Lee H; Tseng SH; Tsai FJ
Cornea; 2008 May; 27(4):476-9. PubMed ID: 18434853
[TBL] [Abstract][Full Text] [Related]
3. Differential expression of vascular endothelial growth factor implies the limbal origin of pterygia.
Gebhardt M; Mentlein R; Schaudig U; Pufe T; Recker K; Nölle B; Al-Samir K; Geerling G; Paulsen FP
Ophthalmology; 2005 Jun; 112(6):1023-30. PubMed ID: 15885787
[TBL] [Abstract][Full Text] [Related]
4. Pterygia: pathogenesis and the role of subconjunctival bevacizumab in treatment.
Mauro J; Foster CS
Semin Ophthalmol; 2009; 24(3):130-4. PubMed ID: 19437347
[TBL] [Abstract][Full Text] [Related]
5. Downregulation of c-Myc in pterygium and cultured pterygial cells.
Cui D; Pan Z; Zhang S; Zheng J; Huang Q; Wu K
Clin Exp Ophthalmol; 2011 Nov; 39(8):784-92. PubMed ID: 22050566
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical analysis of vascular endothelial growth factor (VEGF) and p53 expression in pterygium from Tunisian patients.
Khalfaoui T; Mkannez G; Colin D; Imen A; Zbiba W; Errais K; Anane R; Beltaief O; Zhioua R; Ben Hamida J; Lizard G; Ouertani-Meddeb A
Pathol Biol (Paris); 2011 Jun; 59(3):137-41. PubMed ID: 19481369
[TBL] [Abstract][Full Text] [Related]
7.
Dong S; Wu X; Xu Y; Yang G; Yan M
Mol Vis; 2020; 26():510-516. PubMed ID: 32753832
[TBL] [Abstract][Full Text] [Related]
8. Regulation of vascular endothelial growth factor-C by tumor necrosis factor-α in the conjunctiva and pterygium.
Dong Y; Kase S; Dong Z; Fukuhara J; Tagawa Y; Ishizuka ET; Murata M; Shinmei Y; Ohguchi T; Kanda A; Noda K; Ishida S
Int J Mol Med; 2016 Aug; 38(2):545-50. PubMed ID: 27314284
[TBL] [Abstract][Full Text] [Related]
9. Expression of vascular endothelial growth factor (VEGF) in macrophages, fibroblasts, and endothelial cells in pterygium treated with 5-Fluorouracil.
Hoyama E; Viveiros MM; Shiratori C; de Oliveira DE; Padovani CR; Selva D; Schellini SA
Semin Ophthalmol; 2015 May; 30(3):171-6. PubMed ID: 24171833
[TBL] [Abstract][Full Text] [Related]
10. Angiogenesis in pterygium: study of microvessel density, vascular endothelial growth factor, and thrombospondin-1.
Aspiotis M; Tsanou E; Gorezis S; Ioachim E; Skyrlas A; Stefaniotou M; Malamou-Mitsi V
Eye (Lond); 2007 Aug; 21(8):1095-101. PubMed ID: 16823458
[TBL] [Abstract][Full Text] [Related]
11. Upregulation of Transient Receptor Potential Vanilloid Type-1 Channel Activity and Ca2+ Influx Dysfunction in Human Pterygial Cells.
Garreis F; Schröder A; Reinach PS; Zoll S; Khajavi N; Dhandapani P; Lucius A; Pleyer U; Paulsen F; Mergler S
Invest Ophthalmol Vis Sci; 2016 May; 57(6):2564-77. PubMed ID: 27163769
[TBL] [Abstract][Full Text] [Related]
12. Treatment of pterygium by ligation and bevacizumab injection.
Nakasato H; Uemoto R; Mizuki N
Cornea; 2012 Nov; 31(11):1339-41. PubMed ID: 22710493
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of angiogenin in pterygium body fibroblasts and its association with proliferative potency.
Kim KW; Park SH; Wee SW; Kim JC
Invest Ophthalmol Vis Sci; 2013 Sep; 54(9):6355-62. PubMed ID: 23989187
[TBL] [Abstract][Full Text] [Related]
14. Immunophenotypic characterization of telocyte-like cells in pterygium.
Maxia C; Murtas D; Isola M; Tamma R; Zucca I; Piras F; Ribatti D; Diana A; Perra MT
Mol Vis; 2018; 24():853-866. PubMed ID: 30713424
[TBL] [Abstract][Full Text] [Related]
15. Elevated blood/lymphatic vessel ratio in pterygium and its relationship with vascular endothelial growth factor (VEGF) distribution.
Martín-López J; Pérez-Rico C; García-Honduvilla N; Buján J; Pascual G
Histol Histopathol; 2019 Aug; 34(8):917-929. PubMed ID: 30821336
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical profile of VEGF, TGF-β and PGE₂ in human pterygium and normal conjunctiva: experimental study and review of the literature.
Bianchi E; Scarinci F; Grande C; Plateroti R; Plateroti P; Plateroti AM; Fumagalli L; Capozzi P; Feher J; Artico M
Int J Immunopathol Pharmacol; 2012; 25(3):607-15. PubMed ID: 23058011
[TBL] [Abstract][Full Text] [Related]
17. The effect of subconjunctival ranibizumab on primary pterygium: a pilot study.
Mandalos A; Tsakpinis D; Karayannopoulou G; Tsinopoulos I; Karkavelas G; Chalvatzis N; Dimitrakos S
Cornea; 2010 Dec; 29(12):1373-9. PubMed ID: 20856107
[TBL] [Abstract][Full Text] [Related]
18. Effect of subconjunctival bevacizumab on primary pterygium.
Teng CC; Patel NN; Jacobson L
Cornea; 2009 May; 28(4):468-70. PubMed ID: 19411971
[TBL] [Abstract][Full Text] [Related]
19. The expression of vascular endothelial growth factor in mast cells promotes the neovascularisation of human pterygia.
Liang K; Jiang Z; Zhao B; Shen J; Huang D; Tao L
Br J Ophthalmol; 2012 Sep; 96(9):1246-51. PubMed ID: 22790437
[TBL] [Abstract][Full Text] [Related]
20. Angiogenesis in pterygium: morphometric and immunohistochemical study.
Marcovich AL; Morad Y; Sandbank J; Huszar M; Rosner M; Pollack A; Herbert M; Bar-Dayan Y
Curr Eye Res; 2002 Jul; 25(1):17-22. PubMed ID: 12518239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
